Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeffrey R. Hammersley"'
Publikováno v:
Internal and Emergency Medicine. 13:961-963
Autor:
Jeffrey R. Hammersley, Zubair Khan, Mohammad Taleb, Himani Sharma, Mohammad Saud Khan, Abhinav Tiwari
Publikováno v:
Case Reports in Cardiology
Case Reports in Cardiology, Vol 2017 (2017)
Case Reports in Cardiology, Vol 2017 (2017)
Reversible acetylcholinesterase inhibitors are used as first-line treatment for myasthenia gravis. They improve symptoms by increasing concentration of acetylcholine at the neuromuscular junction and stimulating nicotinic receptors. Serious bradyarrh
Autor:
Jeffrey R. Hammersley, Ryan Griffith
Publikováno v:
Chest. 154:1075A
Autor:
Shahul Valavoor, Shipeng Yu, Ahmed Abdelkarim, Ragheb Assaly, Bryan Hinch, Fadi Safi, Jianlin Tang, Chimaka Mbaso, Jeffrey R. Hammersley, Ali Nawras
Publikováno v:
American journal of therapeutics. 23(2)
Clostridium difficile (C diff) colitis infection is the most common cause of nosocomial infectious diarrhea and the prevalence is increasing worldwide. Toxic megacolon is a severe complication of C diff colitis associated with high mortality. Gastroi
Publikováno v:
American journal of therapeutics. 18(1)
Erlotinib is a Human Epidermal Growth Factor Receptor Type 1/tyrosine kinase (EGFR) inhibitor, which is used for non-small-cell lung cancer treatment. Erlotinib usually has a favorable safety profile however; adverse events such as interstitial lung